Canney Mark, Er Lee, Antonsen John, Copland Michael, Singh Rajinder Suneet, Levin Adeera
Division of Nephrology, University of British Columbia, Vancouver, Canada.
BC Renal, Vancouver, Canada.
Can J Kidney Health Dis. 2021 Feb 15;8:2054358120986265. doi: 10.1177/2054358120986265. eCollection 2021.
Due to inherent challenges in maintaining physical distancing in hemodialysis units, the Canadian Society of Nephrology has recommended peritoneal dialysis as the preferred modality for patients requiring maintenance dialysis during the coronavirus disease 19 (COVID-19) pandemic. However, pursuing peritoneal dialysis is not without risk due to the requirement for in-person contact during catheter insertion and training, and there is a paucity of data regarding the experience of peritoneal dialysis during the early phases of the pandemic.
To examine the incidence and outcomes of peritoneal dialysis between March 17 and June 01, 2020 compared to the same time period in preceding years.
Retrospective observational study.
British Columbia, Canada. After the pandemic was declared on March 17, 2020, patients continued to be trained in peritoneal dialysis. In an effort to limit time spent in hospital, patients were preferentially trained in continuous ambulatory peritoneal dialysis, training times were truncated for some patients, and peritoneal dialysis catheters were inserted by a physician at the bedside whenever feasible.
All patients aged >18 years who started chronic maintenance dialysis during the period March 17 to June 01 in the years 2018 to 2020 inclusive. The time period was extended to include the years 2010 to 2020 inclusive to evaluate longer term trends in dialysis incidence.
A provincial clinical information system was used to capture the date of commencing dialysis, dialysis modality, and complications including peritonitis. Overall uptake of peritoneal dialysis included new starts and transitions to peritoneal dialysis from in-center hemodialysis during the observation period.
The incidence of dialysis during the specified time period, overall and by modality, was calculated per million population using census figures for the population at risk. Patients were followed for a minimum of 30 days from the start of peritoneal dialysis to capture episodes of peritonitis and COVID-19.
A total of 211 patients started maintenance dialysis between March 17 and June 01, 2020. The incidence dialysis rate (41.3 per million population) was lower than that expected based on the 10-year trend from 2010 to 2019 inclusive (expected rate 45.7 per million population, 95% confidence interval 41.7 to 50.1). A total of 93 patients started peritoneal dialysis, including 32 patients who transitioned from in-center hemodialysis, contributing to a higher overall uptake of peritoneal dialysis compared to preceding years. The incidence rate for peritoneal dialysis of 18.2 per million population was higher than that expected (16.3 per million population, 95% confidence interval 14.0 to 19.0). Half of patients (48%) underwent a bedside peritoneal dialysis catheter insertion by a physician. During 30 days of follow-up, 2 (2.2%) patients experienced peritonitis and no patients were diagnosed with COVID-19.
Results are short term and generalizable only to regions with similarly low community rates of transmission of severe acute respiratory syndrome coronavirus 2.
These preliminary findings indicate that peritoneal dialysis can be safely started and perhaps expanded as a means of mitigating the anticipated surge in in-center hemodialysis during the COVID-19 pandemic. Important contributors to the uptake of peritoneal dialysis in British Columbia were bedside catheter insertions and expediting transitions from in-center hemodialysis to peritoneal dialysis.
由于血液透析单位在保持物理距离方面存在固有挑战,加拿大肾脏病学会建议将腹膜透析作为在2019冠状病毒病(COVID - 19)大流行期间需要维持性透析的患者的首选方式。然而,由于在插入导管和培训期间需要面对面接触,开展腹膜透析并非没有风险,而且关于大流行早期腹膜透析经验的数据很少。
研究2020年3月17日至6月1日期间腹膜透析的发生率和结局,并与前几年的同一时期进行比较。
回顾性观察研究。
加拿大不列颠哥伦比亚省。在2020年3月17日宣布大流行后,患者继续接受腹膜透析培训。为了限制住院时间,患者优先接受持续性非卧床腹膜透析培训,部分患者的培训时间被缩短,并且只要可行,腹膜透析导管由医生在床边插入。
所有年龄大于18岁且在2018年至2020年(含)期间3月17日至6月1日开始进行慢性维持性透析的患者。时间段延长至包括2010年至2020年(含),以评估透析发生率的长期趋势。
使用省级临床信息系统记录开始透析的日期、透析方式以及包括腹膜炎在内的并发症。腹膜透析的总体接受情况包括观察期内新开始的患者以及从中心血液透析转为腹膜透析的患者。
使用处于危险中的人口普查数据,按每百万人口计算指定时间段内透析的发生率,总体发生率以及按透析方式计算的发生率。从开始腹膜透析起对患者进行至少30天的随访,以记录腹膜炎和COVID - 19的发病情况。
2020年3月17日至6月1日期间共有211名患者开始维持性透析。透析发生率(每百万人口41.3例)低于基于2010年至2019年(含)10年趋势预期的发生率(预期发生率每百万人口45.7例,95%置信区间41.7至50.1)。共有93名患者开始腹膜透析,其中32名患者从中心血液透析转为腹膜透析,与前几年相比,腹膜透析的总体接受率更高。腹膜透析的发生率为每百万人口18.2例,高于预期(每百万人口16.3例,95%置信区间14.0至19.0)。一半的患者(48%)由医生在床边插入腹膜透析导管。在30天的随访期间,2名(2.2%)患者发生腹膜炎,没有患者被诊断为COVID - 19。
结果是短期的,仅适用于严重急性呼吸综合征冠状病毒2社区传播率同样较低的地区。
这些初步研究结果表明,在COVID - 19大流行期间,腹膜透析可以安全地开展,甚至可能扩大,作为缓解预期的中心血液透析激增的一种手段。在不列颠哥伦比亚省,腹膜透析接受率增加的重要因素是床边导管插入以及加快从中心血液透析向腹膜透析的转变。